In Southeast Wisconsin, Founder Factory is launching startups around validated technologies, not just ideas.
May 13, 2026
All Blog Posts
April 20, 2026
An overview of the ART program at DoW
The Accelerated Research for Transition (ART) program is a Department of War (DoW) initiative designed to help promising SBIR/STTR technologies transition from research into actual military use.
March 10, 2026
SBIR/STTR Alternative: Long Range Broad Agency Announcements (LRBAAs)
Several federal agencies are actively accepting submissions through Long Range Broad Agency Announcements (LRBAAs).
February 24, 2026
NIH Funding Priorities
While we’re all very aware of the challenges tied to the reauthorization process, I also want to keep an eye on topics that matter for the long term— especially for those putting together SBIR proposals in the future.
January 12, 2026
What to do with my NIH SBIR?
Rob Baranowski, MS, JD So, you have an NIH SBIR ready to go, but the SBIR program is still not reauthorized.
January 5, 2026
Unlock Translational Momentum with the Catalyze Grant
The NIH Catalyze program empowers innovators to fast-track heart, lung, blood, and sleep (HLBS) discoveries toward real-world impact.
January 2, 2026
Successful Business Transitioning Characteristics
I was recently asked “What distinguishes SBIR/STTR companies that successfully transition into investor-ready ventures? Are there certain characteristics?” Here are a couple of points that struck me right away.
January 2, 2026
Foreign Risk vs. SBA Red Tape Hotline
This summer we posted about the unfortunate circumstances some of our NIH applicants have had with failing to pass the foreign risk assessment.
January 2, 2026
Is your innovation right for Army FUZE?
The Defense TechConnect Innovation Summit, in conjunction with the SBIR/STTR Fall Innovation Conference was recently held in National Harbor.
December 2, 2025
Department of War deploys six critical technology areas
The US Department of War has announced six critical technology areas (CTS’s) that it will highlight in upcoming research.